IHC analysis of 367 primary invasive BC specimens obtained from patients of a Korean cohort without hematogenous metastasis showed that CD163+ macrophages in tumor nest were an independent prognostic marker of reduced OS and DFS (66). The gene discussed is CD163; the disease is breast cancer.